What's breaking now, across thousands of outlets.
Memorial Sloan Kettering opens up its cancer data through OpenEvidence. Which healthcare and biotech entrepreneurs made the Forbes 400 for the first time. Persistent generic cancer drug shortages. These stories and more in this week’s Forbes InnovationRx newsletter.
We haven't written up this one. Forbes has the full story — the link below goes straight to it.
High-dose vitamin D may improve cognition among those at risk of dementia, according to new research.
(MedPage Today) -- At first, the Federal Register notice set off alarm bells: The secretaries of health and defense were collaborating on emergency use of medical countermeasures for U.S.
Benin’s state deposit institution subscribed units in the Enko PME small-business fund on 11 September. The amount was not disclosed.
Cell and gene therapy developers often struggle to scale manufacturing, according to the authors of a new review, who suggest that part of the problem is the practice of developing unit operations in…
A large survey of adults reveals that emotional intelligence is tied to vigorous exercise habits in women, but not in men.
More predictive, rational therapeutic antibody formulation designs can be grounded in interactions between antibodies and common excipients that biomanufacturers often consider generic.
